Senate Rx Patent Settlement Bill Revised To Limit Reporting Requirements

The revised version of Sen. Patrick Leahy's (D-Vt.) patent settlement notification bill (S 754) would limit the types of generic-brand agreements that would need to be reported to antitrust agencies.